News & Updates
Filter by Specialty:

Two-drug combo rises to the challenge as 1L Tx for mTNBC
In the primary analysis of the ASCENT-04/KEYNOTE-D19 study, a combination regimen comprising sacituzumab govitecan (SG) and pembrolizumab delivers significant progression-free survival (PFS) benefit in women with previously untreated PD-L1+ advanced triple-negative breast cancer (TNBC).
Two-drug combo rises to the challenge as 1L Tx for mTNBC
02 Jul 2025
Add-on olanzapine prevents RT-induced nausea, vomiting
In patients undergoing abdominal-pelvic radiation therapy (RT), treatment with olanzapine along with an antiemetic medication leads to a substantial decrease in RT-induced nausea and vomiting (RINV), with no serious adverse effects, reports a study presented at ASCO 2025.
Add-on olanzapine prevents RT-induced nausea, vomiting
01 Jul 2025
Can diet drinks help with weight management?
Replacing diet beverages with water over 18 months leads to greater weight loss, improved glycaemic control, and higher diabetes remission in women with type 2 diabetes (T2D) and overweight or obesity. The benefits were sustained throughout the 18-month trial.